Journal article

Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Demaria, S., & Dustin, M. (2013). Role of the crosstalk between CTLA-4 and NKG2D in the development of anti-CTLA-4 treatment strategies. Immunotherapy, 5(2), 109–112.

MLA Style

Demaria, S, and M Dustin. “Role of the Crosstalk between CTLA-4 and NKG2D in the Development of Anti-CTLA-4 Treatment Strategies.” Immunotherapy, vol. 5, no. 2, 2013, pp. 109–12.

Chicago Style

Demaria, S, and M Dustin. 2013. “Role of the Crosstalk between CTLA-4 and NKG2D in the Development of Anti-CTLA-4 Treatment Strategies.” Immunotherapy 5 (2): 109–12.
Print

Access Document

Publisher copy:: 10.2217/imt.12.160

Authors

+ Demaria, S More by this author

Role:: Author

+ Dustin, M More by this author

Institution:: University of Oxford
Division:: MSD
Department:: NDORMS
Role:: Author

Journal:: Immunotherapy More from this journal
Volume:: 5
Issue:: 2
Pages:: 109-112
Publication date:: 2013-02-01
DOI:: 10.2217/imt.12.160
EISSN:: 1750-7448
ISSN:: 1750-743X

Language:: English
Keywords:: Neoplasms

Immunological Synapses

Signal Transduction

Antibodies, Monoclonal

T-Lymphocytes

Animals

Immunotherapy

NK Cell Lectin-Like Receptor Subfamily K

Humans

CTLA-4 Antigen
Pubs id:: pubs:426237
UUID:: uuid:ea3d6dd1-461e-46f6-889c-c4391987f45e
Local pid:: pubs:426237
Source identifiers:: 426237
Deposit date:: 2014-07-10
ARK identifier:: ark:/29072/ora_ea3d6dd1461e46f6889cc4391987f45e

Terms of use

Copyright date:: 2013

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP